Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systemic and local immunosuppression in patients with high-grade meningiomas
Yuping D. Li, Dorina Veliceasa, Jason Lamano, et al.
Cancer Immunology Immunotherapy (2019) Vol. 68, Iss. 6, pp. 999-1009
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Emerging systemic treatment options in meningioma
Maximilian J. Mair, Anna S. Berghoff, Priscilla K. Brastianos, et al.
Journal of Neuro-Oncology (2022)
Open Access | Times Cited: 42
Review of Atypical and Anaplastic Meningiomas: Classification, Molecular Biology, and Management
Taylor Wilson, Lei Huang, Dinesh Ramanathan, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 65
Basis for Immunotherapy for Treatment of Meningiomas
Tomás Garzón-Muvdi, Destiny D. Bailey, Mark N. Pernik, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 41
The Tumor Immune Microenvironment in Primary CNS Neoplasms: A Review of Current Knowledge and Therapeutic Approaches
Anita Kalluri, Pavan P. Shah, Michael Lim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2020-2020
Open Access | Times Cited: 11
ADC histogram analysis of tumor-infiltrating CD8+ T cell levels in meningioma
Tao Han, Changyou Long, Xianwang Liu, et al.
Neurosurgical Review (2025) Vol. 48, Iss. 1
Closed Access
Knowledge structures and research hotspots of immunotherapy for brain metastasis, glioma, meningioma, and pituitary adenoma: A bibliometric and visualization review
Donghu Yu, Jin Wang, Lei Hu, et al.
Chinese Chemical Letters (2025), pp. 110995-110995
Closed Access
Chemotherapy and targeted therapies for meningiomas: what is the evidence?
Thomas Graillon, Émeline Tabouret, Olivier Chinot
Current Opinion in Neurology (2021) Vol. 34, Iss. 6, pp. 857-867
Closed Access | Times Cited: 23
Meningioma–Brain Crosstalk: A Scoping Review
Josefine de Stricker Borch, Jeppe Haslund-Vinding, Frederik Vilhardt, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4267-4267
Open Access | Times Cited: 20
The Long and Winding Road: An Overview of the Immunological Landscape of Intracranial Meningiomas
Giuseppe Roberto Giammalva, Lara Brunasso, Federica Paolini, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3639-3639
Open Access | Times Cited: 12
Immune cell infiltration and inflammatory landscape in primary brain tumours
Amalia Luce, Marianna Abate, Giosuè Scognamiglio, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
The Molecular and Immunological Landscape of Meningiomas
Catharina Lotsch, Rolf Warta, Christel Herold‐Mende
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9631-9631
Open Access | Times Cited: 2
NF2 mutation status and tumor mutational burden correlate with immune cell infiltration in meningiomas
John W. Rutland, Corey M. Gill, Joshua Loewenstern, et al.
Cancer Immunology Immunotherapy (2020) Vol. 70, Iss. 1, pp. 169-176
Open Access | Times Cited: 17
Tumour infiltrating lymphocyte density differs by meningioma type and is associated with prognosis in atypical meningioma
Clinton Turner, Jessica McLay, Ian F. Hermans, et al.
Pathology (2022) Vol. 54, Iss. 4, pp. 417-424
Closed Access | Times Cited: 11
Immune checkpoint inhibitor therapy for recurrent meningiomas: a retrospective chart review
Priya Nidamanuri, Jan Drappatz
Journal of Neuro-Oncology (2022) Vol. 157, Iss. 2, pp. 271-276
Open Access | Times Cited: 10
The Current Landscape of Immune Checkpoint Inhibitor Immunotherapy for Primary and Metastatic Brain Tumors
Paolo Alimonti, L. Nicolas Gonzalez Castro
Antibodies (2023) Vol. 12, Iss. 2, pp. 27-27
Open Access | Times Cited: 6
A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in AKT1 E17K Mutated Tumours
Claire Adams, Emanuela Ercolano, Sara Ferluga, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1273-1273
Open Access | Times Cited: 15
The role of systemic inflammatory cells in meningiomas
Jeppe Haslund-Vinding, Jens Möller, Morten Ziebell, et al.
Neurosurgical Review (2021) Vol. 45, Iss. 2, pp. 1205-1215
Closed Access | Times Cited: 13
Advances in Molecular Biological and Translational Studies in World Health Organization Grades 2 and 3 Meningiomas: A Literature Review
Atsushi Okano, Satoru Miyawaki, Yu Teranishi, et al.
Neurologia medico-chirurgica (2022) Vol. 62, Iss. 8, pp. 347-360
Open Access | Times Cited: 9
Programmed death ligand 1 and tumor-infiltrating CD8+ T lymphocytes are associated with the clinical features in meningioma
Yaochuan Zhang, Xiaoliang Wang, Mengwu Shi, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Immunotherapy for Meningiomas
Hans‐Georg Wirsching, Michael Weller
Advances in experimental medicine and biology (2023), pp. 225-234
Closed Access | Times Cited: 4
Volumetric growth rate of incidentally found meningiomas on immunotherapy
Assaf Berger, Reed Mullen, Kenneth Bernstein, et al.
Journal of Neuro-Oncology (2024) Vol. 166, Iss. 2, pp. 303-307
Closed Access | Times Cited: 1
MRI features and tumor-infiltrating CD8 + T cells-based nomogram for predicting meningioma recurrence risk
Tao Han, Xianwang Liu, Changyou Long, et al.
Cancer Imaging (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
A comprehensive neuroimaging review of the primary and metastatic brain tumors treated with immunotherapy: current status, and the application of advanced imaging approaches and artificial intelligence
Xuwen Liu, Hongyan Chen, Guirong Tan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Possible Abscopal Effect Observed in Frontal Meningioma After Localized IMRT on Posterior Meningioma Resection Cavity Without Adjuvant Immunotherapy
Danielle Golub, Kevin Kwan, Jonathan Knisely, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 9
Interdisciplinary Therapeutic Approaches to Atypical and Malignant Meningiomas
Leonidas Trakolis, Athanasios K. Petridis
Cancers (2023) Vol. 15, Iss. 17, pp. 4251-4251
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top